2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03268603 (ClinicalTrials.gov)	October 10, 2017	30/8/2017	Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cellsfor Amyotrophic Lateral Sclerosis (A ...	A Phase II Study of Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cellsfor Amyotrophic ...	ALS;Amyotrophic Lateral Sclerosis	Drug: Autologous Adipose-derived Mesenchymal Stromal Cells	Mayo Clinic	State of Minnesota Regenerative Medicine Minnesota	Recruiting	18 Years	N/A	All	60	Phase 2	United States
2	NCT03828123 (ClinicalTrials.gov)	January 2012	20/7/2017	Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis	A Prospective, Non-randomized, Open Label Study to Assess the Safety and the Efficacy of Autologous ...	Motor Neuron Disease, Amyotrophic Lateral Sclerosis	Biological: Suspension of human autologous MSC 3P in 1.5 ml	Bioinova, s.r.o.	Department of Neurology, University Hospital Motol, Prague, Czech Republic	Completed	18 Years	65 Years	All	26	Phase 1/Phase 2	NULL

First Previous1Next Last